US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CERo Therapeutics Holdings, Inc.

0.0068

0.0000

Volume:1.00

Turnover:0.01

Market Cap:- -

PE:- -

High:0.0068

Open:0.0068

Low:0.0068

Close:0.0068

52wk High:0.0623

52wk Low:0.0037

Shares:- -

Float Shares:- -

Volume Ratio:0.00

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:-210.22%

PB:0.00

PE(LYR):- -

Loading ...

Overview Company News Filings

Company Profile

Company Name:

CERo Therapeutics Holdings, Inc.

Exchange:

PINK

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

http://www.cero.bio

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies. The company was incorporated in 2021 and is based in South San Francisco, California.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CEROW/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"CEROW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CEROW\",,,,,undefined,":{"symbol":"CEROW","market":"US","secType":"STK","nameCN":"CERo Therapeutics Holdings, Inc.","latestPrice":0.0068,"timestamp":1771599174027,"preClose":0.0068,"halted":0,"volume":1,"delay":15,"changeRate":0,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":0,"latestTime":"02-20 09:52:54 EST Delay","open":0.0068,"high":0.0068,"low":0.0068,"amount":0.007122,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1771837200000},"marketStatusCode":7,"adr":0,"exchange":"PINK","adjPreClose":0.0068,"volumeRatio":0.00002787596314560838},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CEROW\",,,,,undefined,":{"symbol":"CEROW","floatShares":0,"roa":"-210.22%","roe":"--","lyrEps":0,"volumeRatio":0.00002787596314560838,"shares":0,"dividePrice":0,"high":0.0068,"amplitude":0,"preClose":0.0068,"low":0.0068,"week52Low":0.0037,"pbRate":"0.00","week52High":0.0623,"institutionHeld":0,"latestPrice":0.0068,"eps":0,"divideRate":0,"volume":1,"delay":15,"open":0.0068,"prevYearClose":0.0089,"prevWeekClose":0.009,"prevMonthClose":0.0068,"prevQuarterClose":0.0089,"fiveDayClose":0.009,"twentyDayClose":0.0089,"sixtyDayClose":0.0091},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CEROW\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-02-15","symbol":"CEROW","reason":null,"defaultRemindTime":1708007400000,"announcedDate":"2024-02-14","type":"delisting","dateTimestamp":1707973200000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CEROW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CEROW\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.cero.bio","description":"CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies. The company was incorporated in 2021 and is based in South San Francisco, California.","exchange":"PINK","name":"CERo Therapeutics Holdings, Inc.","nameEN":"CERo Therapeutics Holdings, Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"CEROW\",market:\"US\",,,undefined,":null}}